Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Katherine S. Hunt"'
Autor:
Mitesh J. Borad, Jan B. Egan, Rachel M. Condjella, Winnie S. Liang, Rafael Fonseca, Nicole R. Ritacca, Ann E. McCullough, Michael T. Barrett, Katherine S. Hunt, Mia D. Champion, Maitray D. Patel, Scott W. Young, Alvin C. Silva, Thai H. Ho, Thorvardur R. Halfdanarson, Robert R. McWilliams, Konstantinos N. Lazaridis, Ramesh K. Ramanathan, Angela Baker, Jessica Aldrich, Ahmet Kurdoglu, Tyler Izatt, Alexis Christoforides, Irene Cherni, Sara Nasser, Rebecca Reiman, Lori Cuyugan, Jacquelyn McDonald, Jonathan Adkins, Stephen D. Mastrian, Riccardo Valdez, Dawn E. Jaroszewski, Daniel D. Von Hoff, David W. Craig, A. Keith Stewart, John D. Carpten, Alan H. Bryce
Publikováno v:
Scientific Reports, Vol 6, Iss 1, Pp 1-12 (2016)
Abstract DNA focused panel sequencing has been rapidly adopted to assess therapeutic targets in advanced/refractory cancer. Integrated Genomic Profiling (IGP) utilising DNA/RNA with tumour/normal comparisons in a Clinical Laboratory Improvement Amend
Externí odkaz:
https://doaj.org/article/0d55a397502a4dbe956a6fd30cff0c29
Autor:
Barbara A. Pockaj, William J. Casey, Nabil Wasif, Paul M. Magtibay, Javier F. Magrina, Kristina A. Butler, Irene T. Ma, Jeffrey L. Cornella, Raman C. Mahabir, Richard Gray, Alanna M. Rebecca, Katherine S. Hunt
Publikováno v:
Annals of Surgical Oncology. 24:77-83
Women considering risk reduction surgery after a diagnosis of breast/ovarian cancer and/or inherited cancer gene mutation face difficult decisions. The safety of combined breast and gynecologic surgery has not been well studied; therefore, we evaluat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8af130b686546b1e54cb43b6312fea8b
https://doi.org/10.1245/s10434-016-5479-6
https://doi.org/10.1245/s10434-016-5479-6
Autor:
Ronald S. Go, Michael John Hovan, Ralitza M Gavrilova, Roshini S. Abraham, Erik C. Thorland, Margot A. Cousin, Katherine S. Hunt, Ann M. Reed, Michael J. Ackerman, Jennifer L. Kemppainen, David R. Linden, Scott A. Beck, Dimitar Gavrilov, Eric W. Klee, Eric D. Wieben, Konstantinos N. Lazaridis, Noralane M. Lindor, David R. Deyle, Michael C. Stephens, Matthew J. Ferber, Timothy B. Niewold, Geoffrey J. Beek, Gianrico Farrugia, Douglas L. Riegert-Johnson, Teresa M. Kruisselbrink, Jennifer B. McCormick, Stephen N. Thibodeau, Kimberly J. Guthrie, Brooke M. McLaughlin, Pavel N. Pichurin, Devin Oglesbee, Elizabeth J. Atkinson, Marine I. Murphree, Kimberly A. Schahl, Linnea M. Baudhuin, Tammy M. McAllister, Dusica Babovic-Vuksanovic, Myra J. Wick, Jennifer L. Hand
Publikováno v:
Mayo Clinic Proceedings. 91:297-307
Objective To describe the experience and outcome of performing whole-exome sequencing (WES) for resolution of patients on a diagnostic odyssey in the first 18 months of an individualized medicine clinic (IMC). Patients and Methods The IMC offered WES
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ede495e39ea5a5d0555dc5c1c25dd456
https://doi.org/10.1016/j.mayocp.2015.12.018
https://doi.org/10.1016/j.mayocp.2015.12.018
Autor:
Alexander Fiksdal, Kara A. Mensink, Matthew J. Ferber, Yuan Ji, Douglas L. Riegert-Johnson, Kelly E. Ormond, Eric W. Klee, W. Edward Highsmith, Kimberly A. Schahl, Jennifer B. McCormick, John L. Black, Eric D. Wieben, Tammy M. McAllister, Umut Aypar, Noralane M. Lindor, Gianrico Farrugia, Stephen N. Thibodeau, Rondell P. Graham, Kiley J. Johnson, Vivek Sarangi, Katherine S. Hunt
Publikováno v:
Mayo Clinic Proceedings. 90:1327-1337
Objective To understand motivations, educational needs, and concerns of individuals contemplating whole-exome sequencing (WES) and determine what amount of genetic information might be obtained by sequencing a generally healthy cohort so as to more e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e1e19eb7bf7dbe5f51e533b15b02ab3f
https://doi.org/10.1016/j.mayocp.2015.05.021
https://doi.org/10.1016/j.mayocp.2015.05.021
Autor:
Jessica B. Langbaum, Rachel A. Lindor, Richard J. Caselli, Jason Scott Robert, Bruce R. Henslin, Gary E. Marchant, Katherine S. Hunt, Amylou C. Dueck
Publikováno v:
Mayo Clinic Proceedings. 89:1389-1396
Objective To explore the self-expressed desire for, envisioned reaction to, and basic understanding of presymptomatic Alzheimer disease (AD)–related genetic and biomarker tests. Patients and Methods The Alzheimer's Prevention Registry is an online
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3701ad37f5ece1aadc9c45891d0de12d
https://doi.org/10.1016/j.mayocp.2014.05.016
https://doi.org/10.1016/j.mayocp.2014.05.016
Autor:
Bruce R. Henslin, Jessica B. Langbaum, Katherine S. Hunt, Heidi E. Kosiorek, Amylou C. Dueck, Jason Scott Robert, Gary E. Marchant, Richard J. Caselli
Publikováno v:
Alzheimer Disease & Associated Disorders. 29:252-254
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ae570e589d7de7974a2709c400db344
https://doi.org/10.1097/wad.0000000000000097
https://doi.org/10.1097/wad.0000000000000097
Autor:
Alvin C. Silva, Alexis Christoforides, Angela Baker, Michael T. Barrett, Rachel M. Condjella, Katherine S. Hunt, Dawn E. Jaroszewski, Tyler Izatt, Jacquelyn McDonald, Thai H. Ho, Mia D. Champion, Stephen D. Mastrian, Daniel D. Von Hoff, Riccardo Valdez, Ramesh K. Ramanathan, Winnie S. Liang, Thorvardur R. Halfdanarson, John D. Carpten, Konstantinos N. Lazaridis, A. Keith Stewart, Mitesh J. Borad, Maitray D. Patel, Irene Cherni, Ahmet Kurdoglu, Rebecca Reiman, Lori Cuyugan, Jessica Aldrich, David Craig, Alan H. Bryce, Ann E. McCullough, Robert R. McWilliams, Sara Nasser, Rafael Fonseca, Scott W. Young, Nicole R. Ritacca, Jonathan Adkins, Jan B. Egan
Publikováno v:
Scientific Reports
Scientific Reports, Vol 6, Iss 1, Pp 1-12 (2016)
Scientific Reports, Vol 6, Iss 1, Pp 1-12 (2016)
DNA focused panel sequencing has been rapidly adopted to assess therapeutic targets in advanced/refractory cancer. Integrated Genomic Profiling (IGP) utilising DNA/RNA with tumour/normal comparisons in a Clinical Laboratory Improvement Amendments (CL
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5c0f430e0759f1ab548698955f6f5c7
Autor:
Rafael Fonseca, Scott W. Young, Rebecca Reiman, John D. Carpten, Mitesh J. Borad, Maitray D. Patel, Angela Baker, Ahmet Kurdoglu, Alan H. Bryce, Alvin C. Silva, Thai H. Ho, Melissa L. Stanton, Jacquelyn McDonald, Scott K. Swanson, John C. Cheville, Daniel D. Von Hoff, Jan B. Egan, Ann E. McCullough, David Craig, Robert R. McWilliams, Jonathan Adkins, Sara Nasser, Stephen D. Mastrian, Lori Cuyugan, Jessica Aldrich, A. Keith Stewart, Rachel M. Condjella, Katherine S. Hunt, Tyler Izatt, Alexis Christoforides, Irene Cherni, Michael T. Barrett, Daniel E. Schneider, Thorvardur R. Halfdanarson, Winnie S. Liang, Nicole R. Ritacca
Publikováno v:
Clinical genitourinary cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0fe8bc2207a35a42aa0537157b2638b1
https://pubmed.ncbi.nlm.nih.gov/28057415
https://pubmed.ncbi.nlm.nih.gov/28057415
Autor:
Leon Raskin, Stephen B. Gruber, Stephen N. Thibodeau, Gad Rennert, Steven Gallinger, Nora Wong, William D. Foulkes, Steven A. Narod, Frank Schwenter, George Chong, Katherine S. Hunt, Faina Bogomolniy, Melyssa Aronson, Douglas A. Levine, Marina Freytsis, Marc Tischkowitz
Publikováno v:
Clinical Genetics. 79:512-522
Founder mutations are an important cause of Lynch syndrome and facilitate genetic testing in specific ethnic populations. Two putative founder mutations in MSH6 were analyzed in 2685 colorectal cancer (CRC) cases, 337 endometrial cancer (EnCa) cases
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db54ad3d0a6cfd892ef919805f7fcf48
https://doi.org/10.1111/j.1399-0004.2010.01594.x
https://doi.org/10.1111/j.1399-0004.2010.01594.x
Autor:
V. Shane Pankratz, Hayden Harvey, Marcia Wilson, Fergus J. Couch, Katherine S. Hunt, Susan M. Domchek, Kiley J. Johnson, M. Cathie Smith, Noralane M. Lindor
Publikováno v:
Familial Cancer. 9:495-502
A number of models have been developed to predict the probability that a person carries a detectable germline mutation in the BRCA1 or BRCA2 genes. Their relative performance in a clinical setting is variable. To compare the performance characteristi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c87720a41273b4333e1fa6788bcd039
https://doi.org/10.1007/s10689-010-9348-3
https://doi.org/10.1007/s10689-010-9348-3